Effectiveness and safety of a novel intranasal influenza vaccine in Chinese children: A phase IV multi-Center, randomized, double-blind, placebo-controlled clinical trial

Ganwu® vaccine provided moderate protection against laboratory-confirmed influenza among children with good safety profile.